BIO 2018: Gottlieb defends naming drug makers, outlines office efforts
08-06-2018
carmendorin / iStockphoto.com
The US Food and Drug Administration (FDA) is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
US Food and Drug Administration, USFDA, generics, funding, competition, drug pricing, Scott Gottlieb
